Sweden · Delayed Price · Currency is SEK ODI Pharma AB Statistics
Total Valuation
ODI Pharma AB has a market cap or net worth of SEK 54.62 million. The enterprise value is 50.44 million.
| Market Cap | 54.62M |
| Enterprise Value | 50.44M |
Important Dates
The last earnings date was Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ODI Pharma AB has 18.33 million shares outstanding. The number of shares has increased by 29.38% in one year.
| Current Share Class | 18.33M |
| Shares Outstanding | 18.33M |
| Shares Change (YoY) | +29.38% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 90.61% |
| Owned by Institutions (%) | n/a |
| Float | 1.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.83 |
| PB Ratio | 30.52 |
| P/TBV Ratio | 30.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 22.75 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.20
| Current Ratio | 1.20 |
| Quick Ratio | 1.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0.20 |
Financial Efficiency
Return on equity (ROE) is -27.54% and return on invested capital (ROIC) is 6.67%.
| Return on Equity (ROE) | -27.54% |
| Return on Assets (ROA) | 0.98% |
| Return on Invested Capital (ROIC) | 6.67% |
| Return on Capital Employed (ROCE) | 7.85% |
| Weighted Average Cost of Capital (WACC) | 8.68% |
| Revenue Per Employee | 29.82M |
| Profits Per Employee | -362,670 |
| Employee Count | 1 |
| Asset Turnover | 3.33 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ODI Pharma AB has paid 4,229 in taxes.
| Income Tax | 4,229 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +76.47% in the last 52 weeks. The beta is 0.81, so ODI Pharma AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +76.47% |
| 50-Day Moving Average | 3.68 |
| 200-Day Moving Average | 2.74 |
| Relative Strength Index (RSI) | 41.21 |
| Average Volume (20 Days) | 14,591 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ODI Pharma AB had revenue of SEK 29.82 million and -362,670 in losses. Loss per share was -0.02.
| Revenue | 29.82M |
| Gross Profit | 8.62M |
| Operating Income | 140,520 |
| Pretax Income | -358,441 |
| Net Income | -362,670 |
| EBITDA | 144,279 |
| EBIT | 140,520 |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 4.19 million in cash and n/a in debt, with a net cash position of 4.19 million or 0.23 per share.
| Cash & Cash Equivalents | 4.19M |
| Total Debt | n/a |
| Net Cash | 4.19M |
| Net Cash Per Share | 0.23 |
| Equity (Book Value) | 1.79M |
| Book Value Per Share | 0.10 |
| Working Capital | 1.78M |
Cash Flow
| Operating Cash Flow | 2.40M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3,759 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 28.90%, with operating and profit margins of 0.47% and -1.22%.
| Gross Margin | 28.90% |
| Operating Margin | 0.47% |
| Pretax Margin | -1.20% |
| Profit Margin | -1.22% |
| EBITDA Margin | 0.48% |
| EBIT Margin | 0.47% |
| FCF Margin | n/a |
Dividends & Yields
ODI Pharma AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.38% |
| Shareholder Yield | -29.38% |
| Earnings Yield | -0.66% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |